Beijing Dingchi Biology Technology Co., Ltd. is a Zhongguancun high-tech enterprise and Beijing's "specialized, refined and innovative" enterprise that mainly engages in the research, development, production and promotion of high-end veterinary biological products. The core members come from the world's top biopharmaceutical and animal health companies and have 20 years of successful development experience in immunology and animal vaccines. 10% of the company's members have a doctorate and 30% have a master's degree. The company has internationally leading subunit and genetic engineering veterinary vaccine development technology. The pipeline under development covers three major sectors: poultry, livestock, and pets, focusing on innovative varieties and major varieties. The core raw materials required for production, such as serum-free culture medium, purified fillers, and a variety of new adjuvants, are self-developed and produced by its subsidiary YSK BIOSCIENCES CO., LTD.. In 2022, the company was successfully selected into the "2022 Investment Community Healthcare Venture 50" list with its outstanding R&D strength, excellent market performance and huge development potential.

VbioSci CO., LTD

Org chart

Teams

Offices